Mark A. Atkinson

Overview

Best Publications

• Type 1 Diabetes

  Mark A Atkinson;George S Eisenbarth;Aaron W Michels

  2955
  Citations

• Type 1 diabetes: new perspectives on disease pathogenesis and treatment

  Mark A Atkinson;George S Eisenbarth

  2165
  Citations

• The Pathogenesis of Insulin-Dependent Diabetes Mellitus

  Mark A. Atkinson;Noel K. Maclaren

  1732
  Citations

• Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

  Daniel L. Kaufman;Michael Clare-Salzler;Jide Tian;Thomas Forsthuber

  1378
  Citations

• Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

  Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  1198
  Citations

• Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes

  S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban

  970
  Citations

• Toward defining the autoimmune microbiome for type 1 diabetes

  Adriana Giongo;Kelsey A. Gano;David B. Crabb;Nabanita Mukherjee

  940
  Citations

• Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes

  Christopher T. Brown;Austin G. Davis-Richardson;Adriana Giongo;Kelsey A. Gano

  877
  Citations

• The NOD mouse model of type 1 diabetes: As good as it gets?

  Mark A. Atkinson;Edward H. Leiter

  825
  Citations

• MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis

  Matthew J Delano;Philip O. Scumpia;Jason S. Weinstein;Dominique Coco

  792
  Citations

• Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

  Ken T. Coppieters;Francesco Dotta;Natalie Amirian;Peter D. Campbell

  752
  Citations

• Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

  D L Kaufman;M G Erlander;M Clare-Salzler;M A Atkinson

  689
  Citations

• Mapping the Human Body at Cellular Resolution -- The NIH Common Fund Human BioMolecular Atlas Program

  Michael P Snyder;Shin Lin;Amanda Posgai;Mark Atkinson

  673
  Citations

• Immunomodulation by Mesenchymal Stem Cells A Potential Therapeutic Strategy for Type 1 Diabetes

  Reza Abdi;Paolo Fiorina;Chaker N. Adra;Mark Atkinson

  666
  Citations

• The “Perfect Storm” for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity

  Outi Vaarala;Mark A. Atkinson;Josef Neu

  645
  Citations

• In Vivo and In Vitro Characterization of Insulin-Producing Cells Obtained From Murine Bone Marrow

  Dong-Qi Tang;Li-Zhen Cao;Brant R. Burkhardt;Chang-Qi Xia

  601
  Citations

• Cellular Immunity to a Determinant Common to Glutamate Decarboxylase and Coxsackie Virus in Insulin-dependent Diabetes

  Mark A. Atkinson;Mark A. Bowman;Lalita Campbell;Bethany L. Darrow

  601
  Citations

• Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors

  Alexandra E. Butler;Martha Campbell-Thompson;Tatyana Gurlo;David W. Dawson

  572
  Citations

• A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.

  Dehuang Guo;Manyu Li;Yan Zhang;Ping Yang

  572
  Citations

• Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes

  Christopher E Lowe;Jason D Cooper;Todd Brusko;Neil M Walker

  539
  Citations

• Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

  Jide Tian;Mark A. Atkinson;Michael Clare-Salzler;Alan Herschenfeld

  528
  Citations